Compounds > hematoporphyrin
Page last updated: 2024-08-21

hematoporphyrin and Prostatic Neoplasms

hematoporphyrin has been researched along with Prostatic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, EH; Choi, KH; Jung, JS; Malkinski, L; Nam, KC; Park, BJ1
Jankun, J1
Małecki, M; Nowak-Stępniowska, A; Padzik-Graczyk, A; Romiszewska, A; Wiktorska, K1
Dolphin, D; Lyster, DM; Thaller, RA1
Chapman, D; Lakey, WH; McPhee, MS; Thomas, G; Thorndyke, CW; Tulip, J1
Andersson, SO; Lofgren, L; Windahl, T1

Other Studies

6 other study(ies) available for hematoporphyrin and Prostatic Neoplasms

ArticleYear
Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.
    Molecules (Basel, Switzerland), 2016, Sep-06, Volume: 21, Issue:9

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cobalt; Contrast Media; Ferric Compounds; Folic Acid; Hematoporphyrins; Humans; Magnetic Fields; Magnetic Resonance Imaging; Male; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms

2016
Protein-based nanotechnology: antibody conjugated with photosensitizer in targeted anticancer photoimmunotherapy.
    International journal of oncology, 2011, Volume: 39, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Line, Tumor; GPI-Linked Proteins; Hematoporphyrins; Humans; Immunoconjugates; Immunotherapy; Light; Male; Models, Molecular; Nanotechnology; Neoplasm Proteins; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms

2011
Cytotoxicity of PP(Arg)(2)- and Hp(Arg)(2)-mediated photodynamic therapy and early stage of apoptosis induction in prostate carcinoma in vitro.
    Acta biochimica Polonica, 2011, Volume: 58, Issue:4

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Darkness; Hematoporphyrins; Humans; Male; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondria; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Protoporphyrins; Time Factors

2011
Potential use of radiolabelled porphyrins for tumor scanning.
    Advances in experimental medicine and biology, 1983, Volume: 160

    Topics: Animals; Breast Neoplasms; Hematoporphyrin Derivative; Hematoporphyrins; Humans; Iron Radioisotopes; Isotope Labeling; Male; Neoplasms; Neoplasms, Experimental; Porphyrins; Prostatic Neoplasms; Radionuclide Imaging; Rats; Structure-Activity Relationship

1983
Interstitial applications of laser irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate cancers.
    Lasers in surgery and medicine, 1984, Volume: 4, Issue:1

    Topics: Animals; Fiber Optic Technology; Hematoporphyrin Derivative; Hematoporphyrins; Laser Therapy; Male; Optical Fibers; Photochemotherapy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Rats

1984
Photodynamic therapy of localised prostatic cancer.
    Lancet (London, England), 1990, Nov-03, Volume: 336, Issue:8723

    Topics: Antineoplastic Agents; Combined Modality Therapy; Hematoporphyrin Derivative; Hematoporphyrins; Humans; Male; Photochemotherapy; Prostatic Neoplasms

1990